These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 25462220)

  • 1. Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
    Ganihigama DU; Sureram S; Sangher S; Hongmanee P; Aree T; Mahidol C; Ruchirawat S; Kittakoop P
    Eur J Med Chem; 2015 Jan; 89():1-12. PubMed ID: 25462220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimycobacterial activity of bisbenzylisoquinoline alkaloids from Tiliacora triandra against multidrug-resistant isolates of Mycobacterium tuberculosis.
    Sureram S; Senadeera SP; Hongmanee P; Mahidol C; Ruchirawat S; Kittakoop P
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2902-5. PubMed ID: 22418278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of novel dispirooxindolopyrrolidine and dispirooxindolopyrrolothiazole derivatives as potential antitubercular agents.
    Mhiri C; Boudriga S; Askri M; Knorr M; Sriram D; Yogeeswari P; Nana F; Golz C; Strohmann C
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4308-13. PubMed ID: 26271585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diarylquinolines, synthesis pathways and quantitative structure--activity relationship studies leading to the discovery of TMC207.
    Guillemont J; Meyer C; Poncelet A; Bourdrez X; Andries K
    Future Med Chem; 2011 Sep; 3(11):1345-60. PubMed ID: 21879841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship of natural and synthetic coumarin derivatives against
    Pires CT; Scodro RB; Cortez DA; Brenzan MA; Siqueira VL; Caleffi-Ferracioli KR; Vieira LC; Monteiro JL; Corrêa AG; Cardoso RF
    Future Med Chem; 2020 Sep; 12(17):1533-1546. PubMed ID: 32820960
    [No Abstract]   [Full Text] [Related]  

  • 6. Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads.
    Tanwar B; Kumar A; Yogeeswari P; Sriram D; Chakraborti AK
    Bioorg Med Chem Lett; 2016 Dec; 26(24):5960-5966. PubMed ID: 27839684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
    de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
    Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in-vitro antimycobacterial evaluation of 1-(cyclopropyl/2,4-difluorophenyl/tert-butyl)-1,4-dihydro- 8-methyl-6-nitro-4-oxo-7-(substituted secondary amino)quinoline-3-carboxylic acids.
    Senthilkumar P; Dinakaran M; Chandraseakaran Y; Yogeeswari P; Sriram D
    Arch Pharm (Weinheim); 2009 Feb; 342(2):100-12. PubMed ID: 19137533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimycobacterial activity: a facile three-component [3+2]-cycloaddition for the regioselective synthesis of highly functionalised dispiropyrrolidines.
    Wei AC; Ali MA; Yoon YK; Ismail R; Choon TS; Kumar RS; Arumugam N; Almansour AI; Osman H
    Bioorg Med Chem Lett; 2012 Aug; 22(15):4930-3. PubMed ID: 22749825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ring-substituted quinolines as potential anti-tuberculosis agents.
    Vangapandu S; Jain M; Jain R; Kaur S; Singh PP
    Bioorg Med Chem; 2004 May; 12(10):2501-8. PubMed ID: 15110831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
    Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
    Bioorg Med Chem; 2008 Mar; 16(6):3408-18. PubMed ID: 18304818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
    Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, antimycobacterial evaluation and pharmacophore modeling of analogues of the natural product formononetin.
    Mutai P; Pavadai E; Wiid I; Ngwane A; Baker B; Chibale K
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2510-3. PubMed ID: 25977095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
    Karabanovich G; Roh J; Smutný T; Němeček J; Vicherek P; Stolaříková J; Vejsová M; Dufková I; Vávrová K; Pávek P; Klimešová V; Hrabálek A
    Eur J Med Chem; 2014 Jul; 82():324-40. PubMed ID: 24927053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A microwave-assisted, facile, regioselective Friedländer synthesis and antitubercular evaluation of 2,9-diaryl-2,3-dihydrothieno-[3,2-b]quinolines.
    Balamurugan K; Jeyachandran V; Perumal S; Manjashetty TH; Yogeeswari P; Sriram D
    Eur J Med Chem; 2010 Feb; 45(2):682-8. PubMed ID: 19944499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of novel quinoline-based carboxylic hydrazides as anti-tubercular agents.
    Chander S; Ashok P; Cappoen D; Cos P; Murugesan S
    Chem Biol Drug Des; 2016 Oct; 88(4):585-91. PubMed ID: 27203404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of acridine and fused-quinoline derivatives as potential anti-tuberculosis agents.
    Muscia GC; Buldain GY; Asís SE
    Eur J Med Chem; 2014 Feb; 73():243-9. PubMed ID: 24412719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant Mycobacterium tuberculosis.
    Krasavin M; Lukin A; Vedekhina T; Manicheva O; Dogonadze M; Vinogradova T; Zabolotnykh N; Rogacheva E; Kraeva L; Yablonsky P
    Eur J Med Chem; 2018 Sep; 157():1115-1126. PubMed ID: 30179748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linked pyridinyl-thiadiazoles: Design and synthesis as potential candidate for treatment of XDR and MDR tuberculosis.
    Mahajan NS; Dhawale SC
    Eur J Med Chem; 2015 Sep; 102():243-8. PubMed ID: 26280920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.